HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Gerger Selected Research

Breast Neoplasms (Breast Cancer)

6/2015Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERĪ±-positive advanced breast cancer.
2/2014Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.
6/2012The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Gerger Research Topics

Disease

13Neoplasms (Cancer)
05/2017 - 01/2008
5Colorectal Neoplasms (Colorectal Cancer)
08/2019 - 11/2011
4Colonic Neoplasms (Colon Cancer)
10/2015 - 04/2014
3Neoplasm Metastasis (Metastasis)
09/2016 - 08/2013
3Breast Neoplasms (Breast Cancer)
06/2015 - 06/2012
2Prostatic Neoplasms (Prostate Cancer)
04/2014 - 03/2014
2Adenocarcinoma
08/2013 - 11/2011
2Skin Neoplasms (Skin Cancer)
02/2008 - 01/2007
1Squamous Cell Carcinoma of Head and Neck
03/2021
1Residual Neoplasm
05/2017
1Osteoporosis
09/2016
1Bone Diseases (Bone Disease)
09/2016
1Multiple Myeloma
09/2016
1Disease Progression
03/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2014
1Sarcoma (Soft Tissue Sarcoma)
10/2013
1Neurofibroma
12/2009
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2007
1Melanoma (Melanoma, Malignant)
01/2003
1Nevus (Nevi)
01/2003

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
08/2019 - 08/2013
2Estrogen ReceptorsIBA
06/2015 - 02/2014
2Cyclin D1IBA
04/2014 - 06/2012
2C-Reactive ProteinIBA
01/2014 - 10/2013
2ParaffinIBA
08/2013 - 11/2011
2Formaldehyde (Formol)FDA Link
08/2013 - 11/2011
2Proteins (Proteins, Gene)FDA Link
08/2013 - 11/2011
1Circulating Tumor DNAIBA
05/2017
1AntibodiesIBA
09/2016
1Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
10/2015
1Fluorouracil (Carac)FDA LinkGeneric
10/2015
1Phosphotransferases (Kinase)IBA
06/2015
1IntegrinsIBA
06/2015
1Voltage-Gated Sodium ChannelsIBA
04/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014
1CateninsIBA
04/2014
1Cadherins (E-Cadherin)IBA
03/2014
1Biological ProductsIBA
03/2014
1MicroRNAs (MicroRNA)IBA
03/2014
1Insulin-Like PeptidesIBA
02/2014
1TamoxifenFDA LinkGeneric
02/2014
1Somatomedin Receptors (Somatomedin Receptor)IBA
02/2014
1Indicators and Reagents (Reagents)IBA
01/2014
1Cysteine (L-Cysteine)FDA Link
08/2013
1Glycoproteins (Glycoprotein)IBA
08/2013
1Lapatinib (GW572016)FDA Link
06/2012
1Capecitabine (Xeloda)FDA Link
06/2012
1thiamine triphosphorate (TTP)IBA
06/2012
1Glucose (Dextrose)FDA LinkGeneric
11/2011
1Endoplasmic Reticulum Chaperone BiPIBA
11/2011
1DNA Transposable Elements (Element, IS)IBA
01/2003

Therapy/Procedure

4Lasers (Laser)
12/2009 - 01/2007
3Therapeutics
03/2021 - 06/2012
3Drug Therapy (Chemotherapy)
10/2015 - 04/2014
2Adjuvant Chemotherapy
10/2015 - 04/2014
2Radiotherapy
04/2014 - 03/2014
1Chemoradiotherapy
03/2021
1Operative Surgical Procedures
12/2009